Daniel Perlman Email & Phone Number

Paoli, Pa, Us

Blue Bell, Pennsylvania, Us

Transformative Pharmaceutical Solutions, LLC (TPS) develops unique platforms designed to transform the Clinical Research Industry. Our integrated suite of people, process, and technology solutions are designed to transform the way Pharmaceutical companies, Biotechnology companies and Investigative Sites monitor clinical trials. Our platforms are designed to integrate with sponsor and site infrastructures, significantly increasing operational transparency, efficiency and overall trial quality.

Founder and CEO of ReSearch Pharmaceutical Services, Inc (RPS)Mr. Perlman has over 20 years of experience as a leader in the Pharmaceutical industry, implementing significant disruptive programs that have revolutionized clinical trial conduct. Mr. Perlman’s solutions were founded on the assumption that Pharmaceutical and Biotechnology companies need to maintain core competencies in-house and outsource non-core competencies and that the ideal operating scenario involved an integrated methodology (providing sponsors with transparency and allowing them to maintain control). Mr. Perlman brought the Functional Service Provider (FSP) model (1998) and Embedded Solutions model (2009) to the industry. For his work, Mr. Perlman was awarded the Industry Innovation Award in 2012. Mr. Perlman founded ReSearch Pharmaceutical Services, Inc. (RPS) in 1998 and resided as Chief Executive Officer and Chairman of the Board through 2013. He grew RPS to approximately $500M in revenue and greater than 5,000 employees operating in over 70 countries by 2013. During his tenure, RPS established itself as a top tier global Contract Research Organization (CRO) with an annualized growth rate of greater than 30%.RPS went public (AIM) in 2008, was taken private with Warburg Pincus in 2011, and subsequently purchased by KKR in 2013 at which time the organization was merged with PRA.Prior to starting RPS, Mr. Perlman served as Executive Vice President of Operating Specialties for Romac, Inc. from 1993 to 1998 (Romac went public as Kforce, Inc .in 1996). Dan subsequently established and grew the Pharmaceutical Division (1995), Healthcare Division (1996), Engineering Division (1996), Scientific Division (1996), Legal Division (1997), and Human Resources Division (1997). Romac’s revenue grew from approximately $50M in 1995 to approximately $1 billion in 1998 when Mr. Perlman departed.